Related references
Note: Only part of the references are listed.Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis
Satoshi Takagi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Lectin microarrays: concept, principle and applications
Jun Hirabayashi et al.
CHEMICAL SOCIETY REVIEWS (2013)
Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors
Vidyalakshmi Chandramohan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody
Shinji Abe et al.
JOURNAL OF IMMUNOLOGY (2013)
Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2
Brett H. Herzog et al.
NATURE (2013)
Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
Satoshi Takagi et al.
PLOS ONE (2013)
Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity
Mika Kato Kaneko et al.
CANCER SCIENCE (2012)
Podoplanin-Rich Stromal Networks Induce Dendritic Cell Motility via Activation of the C-type Lectin Receptor CLEC-2
Sophie E. Acton et al.
IMMUNITY (2012)
Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation
Mika Kato Kaneko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies
Youya Nakazawa et al.
CANCER SCIENCE (2011)
Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation
Anneli Peters et al.
IMMUNITY (2011)
Engineering of the glycan-binding specificity of Agrocybe cylindracea galectin towards α(2,3)-linked sialic acid by saturation mutagenesis
Koji Imamura et al.
JOURNAL OF BIOCHEMISTRY (2011)
Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling
Cara C. Bertozzi et al.
BLOOD (2010)
High sensitivity detection of cancer in vivo using a dual-controlled activation fluorescent imaging probe based on H-dimer formation and pH activation
Mikako Ogawa et al.
MOLECULAR BIOSYSTEMS (2010)
Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas
Yukinari Kato et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Increased expression of highly sulfated keratan sulfate synthesized in malignant astrocytic tumors
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Expression of highly sulfated keratan sulfate synthesized in human glioblastoma cells
Norihito Hayatsu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431
Naho Atsumi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Characterization of anti-podoplanin monoclonal antibodies: Critical epitopes for neutralizing the interaction between podoplanin and CLEC-2
Satoshi Ogasawara et al.
HYBRIDOMA (2008)
Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma
Hiroyuki Suzuki et al.
FEBS LETTERS (2008)
Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells
Katsue Suzuki-Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Functional glycosylation of human podoplanin: Glycan structure of platelet aggregation-inducing factor
Mika Kato Kaneko et al.
FEBS LETTERS (2007)
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome
Ping Yuan et al.
CANCER (2006)
Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma
Kazuhiko Mishima et al.
ACTA NEUROPATHOLOGICA (2006)
Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
K Mishima et al.
ACTA NEUROPATHOLOGICA (2006)
Characterization of human PA2.26 antigen (T1α-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas
E Martín-Villar et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma
Y Kato et al.
TUMOR BIOLOGY (2005)
Functional sialylated O-glycan to platelet aggregation on Aggrus (T1α/podoplanin) molecules expressed in Chinese hamster ovary cells
M Kaneko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors
Y Kato et al.
ONCOGENE (2004)
Molecular identification of Aggrus/T1α as a platelet aggregation-inducing factor expressed in colorectal tumors
Y Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
